MannKind Corporation
INHALED IMATINIB FOR PULMONARY HYPERTENSION
Last updated:
Abstract:
Methods of treatment of pulmonary hypertension comprising dry powder inhalation administration of imatinib, a pharmaceutically acceptable salt, or a derivative thereof, are provided. Dry powder inhalable compositions comprising imatinib, a pharmaceutically acceptable salt, or a derivative thereof, are also provided as well as methods of making the same.
Status:
Application
Type:
Utility
Filling date:
16 Nov 2021
Issue date:
19 May 2022